Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-24-009596

CHIEF MEDICAL OFFICER sold 9,000 shares at $29.50 ($265,500)

  • CHIEF MEDICAL OFFICER acquired 9,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gillies Hunter CHIEF MEDICAL OFFICER 2024-03-28 Option exercise 10b5-1 +9,000 $2.14 $19,260 12,251 D
Gillies Hunter CHIEF MEDICAL OFFICER 2024-03-28 Sale 10b5-1 −9,000 $29.50 $265,500 3,251 D
Derivatives
Gillies Hunter CHIEF MEDICAL OFFICER 2024-03-28 Option exercise · Stock Option (Right to Buy) 10b5-1 −9,000 89,510 D
Open-market sales · 9,000 sh · avg $29.50 · $265,500
Loading xslF345X05/form4-04012024_060401.xml…